Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27.88 USD | 0.00% | +7.27% | +142.43% |
May. 09 | VTv Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 14 | VTv Therapeutics Inc. Announces Board Changes | CI |
Financials (USD)
Sales 2022 | 2.02M | Sales 2023 | - | Capitalization | 23.43M |
---|---|---|---|---|---|
Net income 2022 | -19M | Net income 2023 | -20M | EV / Sales 2022 | 21.1 x |
Net cash position 2022 | 11.42M | Net cash position 2023 | 8.98M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.59
x | P/E ratio 2023 |
-1.18
x | Employees | 16 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.45% |
1 day | +7.73% | ||
1 week | +3.91% | ||
Current month | -0.07% | ||
1 month | +15.54% | ||
3 months | +189.59% | ||
6 months | +92.49% | ||
Current year | +142.43% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CEO | Chief Executive Officer | 65 | 22-07-31 |
Steven Tuch
DFI | Director of Finance/CFO | 56 | 22-12-07 |
Vanessa McDade
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | Feb. 26 | |
Paul Sekhri
CEO | Chief Executive Officer | 65 | 22-07-31 |
Richard Nelson
BRD | Director/Board Member | 54 | 20-11-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 27.88 | 0.00% | 5 569 |
24-05-16 | 27.88 | +7.73% | 1,363 |
24-05-15 | 25.88 | -0.38% | 2,069 |
24-05-14 | 25.98 | +0.31% | 4,922 |
24-05-13 | 25.9 | -0.35% | 2,597 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+142.43% | 67.83M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-4.64% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- VTVT Stock